Latest PFE reports update at 2024-02-22: 202320222021
Pfizer  logo

Pfizer PFE

$ 25.4 0.55%

Country

usaUSA

IPO year

-

Industry

Biotechnology

Stock Exchange

NYSESPB

CEO

Dr. Albert Bourla

Employees in the company

88 300

Shares

5.64 B

Market Cap[1]

$ 143 B

EBITDA (LTM)

$ 9.62 B

P/E (LTM)

12.24

P/S (LTM)

2.58

EPS (LTM)

2.51

Pfizer is a global pharmaceutical company that has been in operation for over 170 years. The company is headquartered in New York City and has a presence in over 150 countries worldwide. Pfizer's mission is to discover, develop, and deliver innovative medicines and vaccines that improve the lives of people around the world.

Pfizer has a diverse portfolio of products that address a range of health conditions, including cardiovascular disease, oncology, inflammation, immunology, and rare diseases. Some of the company's most well-known products include Lipitor, Viagra, and Lyrica.

In addition to developing new treatments, Pfizer is committed to improving access to healthcare for people in need. The company has established partnerships with governments, non-governmental organizations, and healthcare providers to expand access to its medicines and vaccines.

Pfizer is also dedicated to sustainability and reducing its environmental impact. The company has set ambitious goals to reduce greenhouse gas emissions, water consumption, and waste generation across its operations.

As a leading pharmaceutical company, Pfizer is constantly innovating and adapting to meet the changing needs of patients and healthcare providers. With a focus on research and development, access to healthcare, and sustainability, Pfizer is poised to continue making a positive impact on global health for years to come.

Other stocks of industry "Biotechnology"

Issuer Price % 24h Market Cap Exchange Country
Pluristem Therapeutics Pluristem Therapeutics
PSTI
$ 1.03 -1.9 % $ 33.3 M Nasdaq Global Select Market israelIsrael
Cortexyme Cortexyme
CRTX
$ 1.88 -1.05 % $ 67.1 M Nasdaq Global Select Market,SPB usaUSA
Sorrento Therapeutics Sorrento Therapeutics
SRNE
$ 0.27 -29.58 % $ 126 M Nasdaq Global Select Market usaUSA
Cerus Corporation Cerus Corporation
CERS
$ 1.71 0.59 % $ 308 M Nasdaq Global Market usaUSA
Caladrius Biosciences Caladrius Biosciences
CLBS
$ 0.43 -16.75 % $ 25.8 M Nasdaq Capital Market usaUSA
ContraFect Corporation ContraFect Corporation
CFRX
$ 1.47 -5.16 % $ 5.39 M Nasdaq Capital Market usaUSA
Orchard Therapeutics plc Orchard Therapeutics plc
ORTX
$ 4.93 1.02 % $ 90.8 M Nasdaq Global Select Market britainBritain
Cue Biopharma Cue Biopharma
CUE
$ 1.37 -3.19 % $ 62.7 M Nasdaq Capital Market,SPB usaUSA
Advaxis Advaxis
ADXS
$ 0.31 -9.65 % $ 45.9 M Nasdaq Capital Market usaUSA
Dynavax Technologies Corporation Dynavax Technologies Corporation
DVAX
$ 11.21 0.36 % $ 1.44 B Nasdaq Capital Market usaUSA
Heat Biologics, Inc. Heat Biologics, Inc.
HTBX
$ 3.93 -5.76 % $ 99.8 M Nasdaq Capital Market usaUSA
La Jolla Pharmaceutical Company La Jolla Pharmaceutical Company
LJPC
$ 6.2 - $ 154 M Nasdaq Capital Market usaUSA
Zymeworks Zymeworks
ZYME
$ 6.42 - $ 404 M NYSE canadaCanada
Fennec Pharmaceuticals Fennec Pharmaceuticals
FENC
$ 9.21 0.55 % $ 245 M Nasdaq Capital Market usaUSA
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
$ 10.5 - $ 231 M Nasdaq Global Market usaUSA
CEL-SCI Corporation CEL-SCI Corporation
CVM
$ 1.44 -1.71 % $ 68.3 M NYSE American,SPB usaUSA
Kadmon Holdings, Inc. Kadmon Holdings, Inc.
KDMN
$ 9.5 - $ 1.7 B Nasdaq Global Select Market usaUSA
AIkido Pharma AIkido Pharma
AIKI
$ 3.17 1.93 % $ 17.4 M Nasdaq Capital Market usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
$ 2.58 -4.8 % $ 255 M Nasdaq Global Select Market usaUSA
Zosano Pharma Corporation Zosano Pharma Corporation
ZSAN
$ 0.56 7.23 % $ 2.72 M Nasdaq Global Select Market usaUSA

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.